drug of abuse testing market Research Overview 2019
The global drugs of abuse testing market is expected to grow at a CAGR of 5.3% over the forecast period from 2016 to 2020, according to a new research report from Market Research Future (MRFR). The global drug of abuse testing market is profiled in detail in the report, including an analysis of the market’s leading drivers and restraints, key players operating in the market, and the leading segments holding major shares in the market. The historical trajectory of the global drug of abuse testing market is assessed in detail in the report to provide pointers as to the probable growth trajectory of the market over the forecast period. According to the report, the global drugs of abuse testing market is expected to rise to a value of USD 3 billion by the end of the forecast period in 2020.
The global drug of abuse testing market is likely to be driven by the growing awareness about drug of abuse testing and the growing use of illicit drugs all over the world. The increasing number of youth consumers falling prey to addictive substances has led to growing government participation in the drug of abuse testing market. Most governments in the world have come up with and enforce strict drug monitoring policies, which requires large-scale use of drug of abuse testing equipment. This is likely to remain the major driver for the global drug of abuse testing market over the forecast period due to the increasing sophistication of government efforts to fight growing drug usage.
The increasing development of technologically refined, small, portable drug of abuse testing devices is likely to be a major driver for the global drug of abuse testing market over the forecast period. Increasing concern about drug usage among parents has led to an increasing demand for home kits that can be used by parents or other guardians to check whether their ward has consumed drugs. However, while drug of abuse testing equipment can indicate whether an individual has consumed the drug within a specific timeframe, they can’t reveal addiction patterns. This is likely to be a key restraint against the global drugs of abuse testing market over the forecast period.
The global drug of abuse testing market is segmented on the basis of test type and sample type.
By test type, the global drug of abuse testing market is segmented into onsite screening tests and laboratory drug testing. Onsite screening tests are by far the most popular, due to their higher convenience and cost-effectiveness.
On the bases of samples, the drug of abuse testing market is segmented into urine, hair, saliva and others. The urine segment holds the majority share in the global drug of abuse testing market due to the presence of the metabolites of several drugs in urine. The urine segment accounted for 86% of the global drug of abuse testing market in 2015, followed by saliva.
The global drug of abuse testing market is segmented by region into North America, Europe, Asia Pacific, and rest of the world.
North America dominates the global drug of abuse testing market and held a 76.4% share in the overall market in 2015. The stringent enforcement of laws against drug abuse in the U.S. is likely to remain a major driver for the global drugs of abuse testing market over the forecast period, as the U.S. ranks as the top consumer in the global market and is likely to retain the place over the forecast period. Increasing awareness among parents in the U.S. about drug abuse among teenagers is also likely to remain a key driver for the drugs of abuse testing market in North America over the forecast period.
Access Complete Research Details at: https://www.marketresearchfuture.com/reports/drug-abuse-testing-market-1930
Europe is also likely to be a major regional market for drug of abuse testing over the forecast period due to the increasing emphasis on safe driving and eradicating the illegal drugs trade.
Leading players in the global drug of abuse testing market include Roche Holding Limited, Laboratory Corporation of America Holdings, Abbott Laboratories, Psychemedics Corporation, Sonic Healthcare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., Alere Inc., and Quest Diagnostics.
In February 2019, Confirm Biosciences announced that its HairConfirm drug of abuse testing device is now available in retail.